The United States Food and Drug Administration (FDA) has
approved the use of blood plasma extracted from COVID-19 survivors for
treatment.
A statement on Sunday said this was based on scientific
evidence.
“The FDA concluded, as outlined in its decision memorandum,
this product may be effective in treating COVID-19. It also agreed that the
known and potential benefits of the product outweigh the known and potential
risks,” it said
The treatment involves taking blood rich in antibody from
recovered COVID-19 patients (convalescent plasma) and giving the same to those
infected.
FDA Commissioner, Stephen Hahn, said the therapy had shown
35 percent success rate.
“I am committed to releasing safe and potentially helpful
treatments for COVID-19 as quickly as possible in order to save lives. We’re
encouraged by the early promising data that we’ve seen about convalescent
plasma,” he said.
The official added that the treatment still needed to
undergo randomised clinical trials to determine safety and effectiveness.
The trials started in New York and some other states since
April but suffered delays due to insufficient volunteers.
The announcement was made 24 hours after President Donald
Trump accused the FDA of delaying vaccine development and production.
Click to signup for FREE news updates, latest information and hottest gists everyday
Advertise on NigerianEye.com to reach thousands of our daily users
No comments
Post a Comment
Kindly drop a comment below.
(Comments are moderated. Clean comments will be approved immediately)
Advert Enquires - Reach out to us at NigerianEye@gmail.com